Back to LYEL

Foresite Capital Management IV, LLC → LYEL

Foresite Capital Management IV, LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
2
Latest value
$16.1M
Q1 2026
Peak value
$24.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$24.6M
Q1 2026$16.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q1 2026$16.1M800.4K——
Q4 2025$24.6M800.4K——

Other funds holding LYEL

Other Foresite Capital Management IV, LLC positions

PHVS

Pharvaris N.V.

$165.2M
PHVS

Pharvaris N.V.

$151.6M
PHVS

Pharvaris N.V.

$135M
PHVS

Pharvaris N.V.

$132.6M
CYTK

CYTOKINETICS INC

$60.9M
CYTK

CYTOKINETICS INC

$47.1M
CYTK

CYTOKINETICS INC

$33.2M
CYTK

CYTOKINETICS INC

$29.1M